These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8747034)

  • 1. Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea.
    Genazzani AD; Gastaldi M; Petraglia F; Battaglia C; Surico N; Volpe A; Genazzani AR
    Hum Reprod; 1995 Nov; 10(11):2868-71. PubMed ID: 8747034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea.
    Genazzani AD; Petraglia F; Gastaldi M; Volpogni C; Gamba O; Genazzani AR
    Fertil Steril; 1995 Nov; 64(5):951-6. PubMed ID: 7589640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment.
    Armeanu MC; Berkhout GM; Schoemaker J
    Fertil Steril; 1992 Apr; 57(4):762-70. PubMed ID: 1555686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile administration of gonadotrophin releasing hormone and oral administration of naltrexone in hypothalamic amenorrhoea.
    Leyendecker G; Waibel-Treber S; Wildt L
    Hum Reprod; 1993 Nov; 8 Suppl 2():184-8. PubMed ID: 8276957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of opioid antagonism with naltrexone on pulsatile luteinizing hormone secretion in women with hypothalamic amenorrhea in basal conditions and after discontinuation of treatment with pulsatile LHRH.
    Armeanu MC; Lambalk CB; Berkhout GM; Schoemaker J
    Gynecol Endocrinol; 1992 Mar; 6(1):3-12. PubMed ID: 1580165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation.
    Perkins RB; Hall JE; Martin KA
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1905-11. PubMed ID: 10372685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of altered dopaminergic modulation of Prl, LH and TSH secretion in patients with normoprolactinaemic amenorrhoea.
    Hagen C; Petersen K; Djursing H; Andersen AN
    Acta Endocrinol (Copenh); 1984 May; 106(1):8-14. PubMed ID: 6428118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of ovulation with chronic intermittent (pulsatile) administration of Gn-RH in women with hypothalamic amenorrhoea.
    Leyendecker G; Wildt L
    J Reprod Fertil; 1983 Sep; 69(1):397-409. PubMed ID: 6411917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone must not be considered a real therapy in functional hypothalamic amenorrhea. The results of a double blind controlled study.
    Manieri C; Musso MC; Marolda AR; Pastorino R; Ferrarotti M; Fornengo R; Isolato G; Messina M
    Panminerva Med; 1993 Dec; 35(4):214-7. PubMed ID: 8202334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate antagonist treatment of ovarian failure.
    Wildt L; Sir-Petermann T; Leyendecker G; Waibel-Treber S; Rabenbauer B
    Hum Reprod; 1993 Nov; 8 Suppl 2():168-74. PubMed ID: 8276953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy.
    Wildt L; Leyendecker G; Sir-Petermann T; Waibel-Treber S
    Hum Reprod; 1993 Mar; 8(3):350-8. PubMed ID: 8473447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic naltrexone treatment induces desensitization of the luteinizing hormone pulse generator for opioid blockade in hyperprolactinemic patients.
    de Wit W; Schoute E; Schoemaker J
    J Clin Endocrinol Metab; 1995 May; 80(5):1739-42. PubMed ID: 7745028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea.
    Genazzani AD; Stomati M; Bersi C; Luisi S; Fedalti M; Santuz M; Esposito G; Petraglia F; Genazzani AR
    J Endocrinol Invest; 2000 Sep; 23(8):526-32. PubMed ID: 11021769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estriol administration modulates luteinizing hormone secretion in women with functional hypothalamic amenorrhea.
    Genazzani AD; Meczekalski B; Podfigurna-Stopa A; Santagni S; Rattighieri E; Ricchieri F; Chierchia E; Simoncini T
    Fertil Steril; 2012 Feb; 97(2):483-8. PubMed ID: 22137494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical guide to the diagnosis and management of amenorrhoea.
    Crosignani PG; Vegetti W
    Drugs; 1996 Nov; 52(5):671-81. PubMed ID: 9118817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced frequency of luteinizing hormone pulses in women with weight loss-related amenorrhoea and multifollicular ovaries.
    Mason HD; Sagle M; Polson DW; Kiddy D; Dobriansky D; Adams J; Franks S
    Clin Endocrinol (Oxf); 1988 Jun; 28(6):611-8. PubMed ID: 3151067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing hormone pulsatile release and the length of lactational amenorrhoea.
    Díaz S; Cárdenas H; Zepeda A; Brandeis A; Schiappacasse V; Miranda P; Serón-Ferré M; Croxatto HB
    Hum Reprod; 1995 Aug; 10(8):1957-61. PubMed ID: 8567822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of ovulation by the chronic administration of naltrexone in hypothalamic amenorrhea.
    Wildt L; Leyendecker G
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1334-5. PubMed ID: 3571432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of hypothalamic progestin-nonresponsive amenorrhea by secretion pattern of serum LH.
    Kondoh Y; Uemura T; Minaguchi H
    Endocr J; 1997 Aug; 44(4):501-8. PubMed ID: 9447282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.